# Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally.

> **NCT01735240** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 15 (actual)

## Conditions studied

- Asthma,
- Pharmacokinetics,
- Cmax,
- Tmax,
- λz,
- AUC,
- Ketoconazole,
- Metabolite

## Interventions

- **DRUG:** AZD5069
- **DRUG:** Ketoconazole

## Key facts

- **NCT ID:** NCT01735240
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2015-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01735240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01735240, "Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01735240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*